VE-03702

N/A

Report date: 2025/05/19 16:53:05
NME

Base Information

Drug NameVE-03702
Drug Alias NameVE-03702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWeishen Pharmaceutical (Nantong) Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesWeishen Pharmaceutical (Nantong) Co., Ltd.
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A